Latest news with #healthsystems
Forbes
5 days ago
- Business
- Forbes
As Trump Cuts Healthcare, Private Equity Gains Hold At Doctor's Office
Just two in five U.S. physicians are in doctor-owned private practice as hospitals and private equity firms gobble up physician groups thanks in part to cuts in insurance payments to medical care providers that are about to get even worse. The American Medical Association, the nation's largest physician group, says in a new report that the share of physicians working in private practice was 42.2% last year, which is a sharp decline from more than a decade ago when more than 60% -- or three in five doctors – were in private practice, which the AMA defines as a 'practice wholly owned by physicians.' The AMA's analysis blames flat to falling payments from health insurance companies and government health programs like Medicare coverage for the elderly and Medicaid coverage for low-income Americans among the reasons physicians are selling to hospitals, health systems and private equity. In addition, AMA says its data cites 'costly resources, and burdensome regulatory and administrative requirements' as 'longstanding and important drivers of this change.' 'The share of doctors working in practices wholly owned by physicians is unraveling under compounding pressures,' said AMA President Dr. Bruce A. Scott said. 'The cumulative impact of burdensome regulations, rising financial strain, and relentless cuts in payment poses a dire threat to the sustainability of private practices," Scott said. "After adjusting for inflation in practice costs, Medicare physician payment has fallen 33 percent over the past quarter century, which has severely destabilized private practices and jeopardized patients' access to care. Payment updates are necessary for physicians to continue to practice independently.' But there appears to be little interest by the Republican-controlled Congress to boost payments to physicians. The AMA report comes as Republicans in Congress and the Donald Trump White push for more cuts in federal health insurance programs, including Medicaid and Medicare, which would most certainly spill over onto doctor practices as more Americans lose health insurance. Last week, a new analysis published by the Robert Wood Johnson Foundation of the budget reconciliation bill passed by the U.S. House of Representatives shows physicians and other healthcare providers 'could lose more than $770 billion in revenue over the next decade as a result of more than 11 million people losing health coverage through Medicaid and the Affordable Care Act marketplaces.' The budget still faces approval by the U.S. Senate and would need to be signed into law by Trump. Meanwhile, more and more physicians are working for hospitals or companies owned by private equity no matter their medical discipline. 'Private practices now account for less than half of physicians in most medical specialties, ranging from 30.7 percent in cardiology to 46.9 percent in radiology,' the AMA said of its report. 'Exceptions included orthopedic surgery (54 percent), ophthalmology (70.4 percent), and other surgical subspecialties (51.2 percent).' The share of physicians working in hospital-owned practices increased to more than one-third, or 34.5 percent last year. 'Twelve percent of physicians were employed directly by a hospital (or contracted directly with a hospital), double the share (5.6 percent) in 2012,' the AMA said. 'In 2024, 6.5 percent of physicians characterized their practice as private equity-owned, higher than the shares in 2020 and 2022, which were both around 4.5 percent, the report noted.'
Argaam
20-05-2025
- Business
- Argaam
2P wins SAR 122M maintenance contract in Eastern Health Cluster
Perfect Presentation for Commercial Services Co. (2P) won a SAR 122.2 million contract, inclusive of VAT, to operate and maintain digital health systems at the Eastern Health Cluster, the company said in a statement to Tadawul. The contract covers maintenance, operation, and technical support for computer systems, networks, infrastructure, applications, and storage at the cluster's facilities in the Eastern Province, including King Fahad Specialist Hospital in Dammam. The financial impact is expected to reflect positively from 2025 through 2030. 2P said there are no related parties to the agreement.
Entrepreneur
16-05-2025
- Health
- Entrepreneur
Global Health Setbacks Expose Deep Fault Lines as 2030 Targets Loom
WHO's Fourteenth General Programme of Work (2025–2028) aims to recalibrate global health ambitions---the new targets include keeping 6 billion people healthier, expanding affordable care access to 5 billion, and better protecting 7 billion from health emergencies You're reading Entrepreneur India, an international franchise of Entrepreneur Media. As the world enters the final stretch toward the 2030 deadline for achieving health-related Sustainable Development Goals (SDGs), a sobering new report by the World Health Organization (WHO) paints a picture of hard-won progress at risk of being undone. According to the World Health Statistics 2025 report, the COVID-19 pandemic has erased over a decade's worth of health gains, widened inequalities, and left critical global targets out of reach. Between 2000 and 2019, global healthy life expectancy (HALE) rose from 58.1 to 63.5 years—largely due to reductions in deaths from infectious diseases and childhood illnesses. But the pandemic triggered a sharp 1.6-year drop in HALE within just two years, with adults aged 30 and above bearing the brunt. COVID-related deaths, along with a rise in mental health disorders like depression and anxiety, significantly contributed to this decline. "The pandemic didn't just disrupt health systems, it reversed decades of progress," said Dr Tedros Adhanom Ghebreyesus, WHO's Director-General. He adds, "Stronger data systems and more equitable health delivery are no longer optional, they are essential." Missed milestones and stalled momentum The report underscores that most countries are not on track to meet targets such as reducing premature deaths from noncommunicable diseases (NCDs), lowering maternal and child mortality, and tackling environmental health risks. While there have been modest declines in global mortality from conditions like stroke, heart disease, and respiratory infections, these are being offset by demographic pressures and growing disease burdens in vulnerable populations. The slowdown is particularly stark when viewed against past momentum. For instance, while maternal mortality fell by one-third and child deaths halved between 2000 and 2019, progress has since stalled. Meanwhile, the global burden of diseases linked to air pollution, unsafe water, poor nutrition, and alcohol consumption remains alarmingly high. Universal health coverage: still a distant goal Progress on universal health coverage (UHC)—one of WHO's "Triple Billion" goals remains sluggish. As of 2024, only 431 million more people have gained access to essential health services without financial hardship since 2018, far short of the one-billion target. Moreover, 13.5 per cent of the global population still spends more than 10 per cent of their household income on health-related out-of-pocket expenses. The report estimates that 344 million people were pushed further into extreme poverty in 2019 due to healthcare costs, a stark reminder of how fragile financial protection remains in many parts of the world. Workforce woes and immunisation gaps The global shortage of healthcare workers remains another bottleneck. Although the shortfall decreased from 15.4 million in 2020 to 14.7 million in 2023, projections suggest a gap of 11.1 million will persist by 2030, with nearly 70 per cent of it concentrated in Africa and the Eastern Mediterranean. Childhood immunisation coverage has improved overall, yet disparities persist especially among populations living in remote areas, urban slums, or conflict zones. Encouragingly, economic-related inequality in vaccine access has narrowed in low-income countries, with DTP3 coverage gaps reducing by more than half in the last decade. Ambitious, but necessary In response to the slow pace of progress, WHO's Fourteenth General Programme of Work (2025–2028) aims to recalibrate global health ambitions. The new targets include keeping 6 billion people healthier, expanding affordable care access to 5 billion, and better protecting 7 billion from health emergencies. "Behind every data point is a person, a child who didn't reach their fifth birthday, a mother lost in childbirth, a life cut short by a preventable disease," said Adhanom Ghebreyesus.
Associated Press
14-05-2025
- Business
- Associated Press
Quva Adds a New, Forward Distribution Center to Its Industry Leading Integrated 503B and Data Services Platform
The company's new Sugar Land, TX distribution facility is the second for Quva, as it expands its 503B forward distribution capabilities and adds another 20,000 sq. ft. of distribution capacity. The forward distribution facilities complement Quva's integrated services platform and are designed to redefine service expectations and create greater resiliency and reliability for Quva's health system and hospital customers. SUGAR LAND, Texas, May 14, 2025 /PRNewswire/ -- QuVa Pharma, Inc. ('Quva') announced today that it has added another forward distribution center to its existing 503B sterile injectable compounded medications platform. Quva now has two dedicated forward distribution facilities, with the new 20,000 sq. ft. distribution facility in Sugar Land, TX providing additional overall capacity beyond that offered by the company's existing 40,000 sq. ft. distribution facility in Phoenix, AZ. Located in close proximity to Quva's Sugar Land, TX manufacturing operations, this new forward distribution center was designed to meet the growing demand for secure, efficient, and compliant product handling and shipping. It enhances the company's supply chain capabilities with cutting-edge infrastructure that supports cold chain and DEA regulatory compliance. This new facility represents a major investment in operational excellence and regulatory compliance and further increases capacity in Quva's production facilities. Furthermore, this distribution facility will be co-located with Quva's new, state-of-the-art IV bag production operations that will implement automated processes that improve bag operations from end-to-end manufacturing—this is scheduled to be operational in the second half of 2026 and increase Quva's overall production capacity to three facilities and over 260,000 across its network. 'Quva is building a new future of reliability and transparency for our industry. This newest distribution center is progress in our mission to provide high quality and effective medications and services to facilitate efficient and accurate delivery of patient care,' said Stuart Hinchen, Quva co-founder and CEO. 'We understand hospitals' need for the right drug at the right time and in the right quantities, and with uncertainties like tariffs and DSCSA implementation being front and center for our customers, this added capability to increase access and reliability is critical to help meet those expectations.' About Quva Quva is a national, industry-leading provider of health-system pharmacy services and solutions, including 503B sterile injectable outsourcing and data software solutions that generate insights to help power the business of pharmacy. The company's Quva Pharma solutions are offered by its FDA-registered 503B outsourcing facilities, which provide hospitals with essential medications in ready-to-administer formats that are critical to effective patient care. Based upon Quva's cGMP and pharmaceutical manufacturing expertise, broad sterile-to-sterile product portfolio, expansive capacity across multiple production facilities leveraging automation and integrated technologies, dedicated forward distribution capabilities, transparent and accountable customer service, and a patient-first safety orientation, its Quva Pharma solutions help hospitals better meet their patient care and operational needs while reducing compliance risk. The company's Quva BrightStream predictive analytics and data insights software solutions provide health systems with the ability to aggregate, normalize, and analyze large amounts of complex data across sites of care. Through a proprietary machine learning and AI platform, complex data is transformed into actionable insights supporting revenue optimization, script capture, inventory management, drug shortage control, and more, enabling health-system pharmacies the clarity to make better decisions. Quva's overall progressive and integrated platform helps health-systems transform pharmacy management to achieve greater value by operating more efficiently and effectively in delivering high-quality patient care. For more information, please visit or follow Quva on LinkedIn at View original content to download multimedia: SOURCE QuVa Pharma, Inc.
